Amino acid Metabolism Disorders Treatment Market Expected to Reach $961.8 Million by 2031

Amino acid metabolism disorders treatment market was valued at $630.92 million in 2021, and is estimated to reach $961.8 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031. Metabolism is the process which the body uses to make energy from the food eaten. Food is made up of proteins, carbohydrates, and fats. The digestive system breaks the food parts down into sugars and acids which are also called as the body’s fuel. The body can use this fuel right away, or it can store the energy in the body. If a person has a metabolic disorder, then the metabolism process gets harmed and impacted severely. Amino acids are the organic compounds which contains carboxyl and amine functional groups attached to carbon chain. Amino acid metabolism disorders occurs due to excessive build-up of amino acids such as methionine, homocystine, and phenylalanine in the body. This is attributed to improper metabolism of amino acids.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Kyowa Hakko Kirin Co., Ltd., Shine Star (Hubei) Biological Engineering Co., Pfizer, Inc., AMINO GmbH, Sanofi, Civentichem, LLC, Ltd., Teva Pharmaceutical Industries Ltd., BioMarin Pharmaceutical Inc., GlaxoSmithKline PLC, Koninklijke DSM N.V., Recordati S.p.A., Merck KGaA

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/11233

By product type, the market is divided into folic acid, vitamin B6 and B12, arginine, thiamine, betaine, sapropterin, and others. The sapropterin segment exhibited the highest growth in 2021, owing to amino acid metabolism disorders treatment market trends like increase in prevalence of phenylketonuria and increase in demand for sapropterin in developed countries such as the U.S. and Germany. However, betaine segment is expected to register highest CAGR of 5.4% from 2022 to 2031, owing to increase in product offering for betaine by key market players.

By indication, the market is classified as phenylketonuria, maple syrup urine disease, citrullinemia, homocystinuria, and argininosuccinic aciduria. The phenylketonuria segment exhibited the highest growth in 2021, owing to increase in prevalence of phenylketonuria and mandatory newborn screening for the diagnosis of phenylketonuria and other amino acid metabolism disorders. However, maple syrup urine disease segment is expected to register highest CAGR of 5.5% from 2022 to 2031, owing to increase in prevalence of maple syrup urine disease and development of new therapies for the treatment of maple syrup urine disease.

By distribution channel, the market is classified as hospital pharmacies, drug stores and retail pharmacies, and online providers. The drug stores and retail pharmacies segment dominated the market in 2021 and is expected to remain dominant during the forecast period. The market growth of this segment driven by increase sell of prescription drugs and OTC drugs. However, online providers is expected to register highest CAGR of 6.0% from 2022 to 2031, owing to shift of patients preference to buy medicine online since the covid pandemic period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/11233

Region wise, North America has the highest amino acid metabolism disorders treatment market share in 2021, and is expected to maintain its lead during the forecast period, owing to increase in demands for sapropterin and Kuvan for amino acid metabolism disorders treatments. Moreover, the North America advances due to availability of treatments and well established healthcare infrastructure. However, Asia-Pacific is expected to register highest CAGR of 5.5% during the amino acid metabolism disorders treatment market forecast period, owing to increase in prevalence amino acid metabolism disorders and rise in patients seeking treatment for amino acid metabolism disorders.

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com